Cargando…
Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520396/ https://www.ncbi.nlm.nih.gov/pubmed/31092813 http://dx.doi.org/10.1038/s41408-019-0207-7 |
| _version_ | 1783418734150418432 |
|---|---|
| author | Shea, Lauren K. Honjo, Kazuhito Redden, David T. Tabengwa, Edlue Li, Ran Li, Fu-Jun Shakhmatov, Mikhail Chiorazzi, Nicholas Davis, Randall S. |
| author_facet | Shea, Lauren K. Honjo, Kazuhito Redden, David T. Tabengwa, Edlue Li, Ran Li, Fu-Jun Shakhmatov, Mikhail Chiorazzi, Nicholas Davis, Randall S. |
| author_sort | Shea, Lauren K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6520396 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65203962019-05-16 Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status Shea, Lauren K. Honjo, Kazuhito Redden, David T. Tabengwa, Edlue Li, Ran Li, Fu-Jun Shakhmatov, Mikhail Chiorazzi, Nicholas Davis, Randall S. Blood Cancer J Article Nature Publishing Group UK 2019-05-15 /pmc/articles/PMC6520396/ /pubmed/31092813 http://dx.doi.org/10.1038/s41408-019-0207-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Article Shea, Lauren K. Honjo, Kazuhito Redden, David T. Tabengwa, Edlue Li, Ran Li, Fu-Jun Shakhmatov, Mikhail Chiorazzi, Nicholas Davis, Randall S. Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status |
| title | Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status |
| title_full | Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status |
| title_fullStr | Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status |
| title_full_unstemmed | Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status |
| title_short | Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status |
| title_sort | fc receptor-like 2 (fcrl2) is a novel marker of low-risk cll and refines prognostication based on ighv mutation status |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520396/ https://www.ncbi.nlm.nih.gov/pubmed/31092813 http://dx.doi.org/10.1038/s41408-019-0207-7 |
| work_keys_str_mv | AT shealaurenk fcreceptorlike2fcrl2isanovelmarkeroflowriskcllandrefinesprognosticationbasedonighvmutationstatus AT honjokazuhito fcreceptorlike2fcrl2isanovelmarkeroflowriskcllandrefinesprognosticationbasedonighvmutationstatus AT reddendavidt fcreceptorlike2fcrl2isanovelmarkeroflowriskcllandrefinesprognosticationbasedonighvmutationstatus AT tabengwaedlue fcreceptorlike2fcrl2isanovelmarkeroflowriskcllandrefinesprognosticationbasedonighvmutationstatus AT liran fcreceptorlike2fcrl2isanovelmarkeroflowriskcllandrefinesprognosticationbasedonighvmutationstatus AT lifujun fcreceptorlike2fcrl2isanovelmarkeroflowriskcllandrefinesprognosticationbasedonighvmutationstatus AT shakhmatovmikhail fcreceptorlike2fcrl2isanovelmarkeroflowriskcllandrefinesprognosticationbasedonighvmutationstatus AT chiorazzinicholas fcreceptorlike2fcrl2isanovelmarkeroflowriskcllandrefinesprognosticationbasedonighvmutationstatus AT davisrandalls fcreceptorlike2fcrl2isanovelmarkeroflowriskcllandrefinesprognosticationbasedonighvmutationstatus |